Rekonas

What Rekonas does

Rekonas GmbH is a Basel, Switzerland-based medical technology company founded in 2020 that provides an end-to-end platform for ambulatory sleep research. The company's stack combines proprietary hardware — a multi-sensor headband integrating a modular detachable washable strap, dry-electrode multi-channel EEG, EOG, PPG (HR, HRV, SpO2), and a high-resolution accelerometer for sleep position and activity recognition — with a Simple Patient App guiding in-home recording and a centralized Researcher Portal for participant management, real-time dashboards, and data export. The system is validated for accuracy against polysomnography, the gold-standard, and holds Swissmedic Medical Device Class I notification (CH-202106-0020, dated 25 May 2021) under the Swiss Medical Devices Ordinance.

Rekonas targets two primary customer segments: clinical researchers in Pneumology conducting multi-night sleep-disordered-breathing studies (e.g., sleep apnea, PRISm) and clinical researchers in Neurology studying neurological aspects of sleep disorders, with anchor research partnership at Universitätsspital Basel Department of Pneumology (Dr. Med. Matthias Herrmann). The platform supports studies of 3 to 365 nights per participant and 10 to 2,000 participants, addressing the prohibitive costs, logistical complexity, and unnatural environment of traditional sleep lab PSG studies. The company also references three additional named software modules — Venea, Somnus, and Sleep Stager — accessible through its login portal, and operates a consumer sub-brand (Somnolinc) promoted via a 2025 Kickstarter campaign.

Go-to-market is direct enterprise field sales with a 'Request a Demo' funnel, custom quotes based on study parameters, and a grant-friendly, fixed one-time perpetual-license pricing model with no recurring subscriptions and multi-year contracts. The company is pre-seed stage (Blue Lion Acceleration Program Spring 2025 cohort of 10 pre-seed startups), has no disclosed funding rounds or revenue, and depends on non-dilutive institutional support from Innosuisse, BRIDGE, Chips-JU, SERI, SIPBB, and DayOne Accelerator, alongside its commercial program with Universitätsspital Basel and Universitäts-Kinderspital beider Basel.

Name

Rekonas

Legal name

Rekonas GmbH

Website

https://rekonas.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

1–10 employees

Short description

Rekonas is a Basel-based medical-technology company providing an end-to-end ambulatory sleep research platform — multi-sensor EEG headband hardware plus patient app and researcher portal — for clinical researchers in pneumology and neurology conducting multi-night in-home sleep studies.

Ownership category

akta.pro rank

Product category

Sleep Research Technology Platform

NAICS

Computer Systems Design and Related Services (54151), Computer Systems Design Services (541512)

SIC

Services-Computer Programming Services (7371), Services-Computer Programming, Data Processing, Etc. (7370)

akta.pro primary industry

Sleep Diagnostics & Monitoring (PSG/Home Sleep Testing, Actigraphy) (HLAHAGAB)

akta.pro secondary industries

Pulmonology & Sleep Medicine Telemedicine Platforms (HLALAGAF), Remote Therapeutic Monitoring (RTM) & Digital Rehabilitation Platforms (HLALABAK)

Keywords

• Ambulatory EEG monitoring
• Sleep research platform
• Clinical research software
• Polysomnography validation
• Medical device platform

Headquarters

HQ city

Basel

HQ country

Switzerland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain

Revenue model

1. Hardware and Software Platform Sales: Fixed one-time cost model for complete platform including headband device and all-inclusive software access. No recurring subscriptions. Grant-friendly pricing well-suited for research grants enabling predictable budgeting.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Rekonas provides an end-to-end platform for ambulatory sleep research, combining a proprietary multi-sensor EEG headband hardware device with a cloud-integrated software ecosystem (Patient App and Researcher Portal). The platform enables scalable, multi-night sleep studies conducted in patients' homes, replacing traditional sleep lab settings. The system is validated for accuracy against polysomnography (the gold-standard) and is notified as a Swissmedic Medical Device Class I (CH-202106-0020).

Product overview

Rekonas provides an end-to-end platform for ambulatory sleep research combining hardware (the Rekonas RS-Pro modular headband with multi-sensor EEG, EOG, PPG, and accelerometer capabilities), a patient-facing mobile application, and a centralized researcher portal/web dashboard. The platform enables scalable, multi-night sleep studies from patients' homes, replacing traditional expensive sleep lab settings. The ecosystem includes the Multi-Sensor Headband for data capture, Simple Patient App for patient guidance, and Centralized Researcher Portal for study management and analytics. Additional platforms referenced include Venea, Somnus, and Sleep Stager accessible through the login portal.

Differentiator

Problem solved

Functional benefit

Brands

• Somnolinc: Consumer sleep headband brand mentioned in Kickstarter campaign for 'The Smart Headband That Helps You Sleep' with medical-grade tracking and personalized coaching.

Products and services

• Rekonas RS-Pro Headband Next-generation modular headband device with dry EEG sensor array and integrated multi-channel sensors (EEG, EOG, PPG, accelerometer) designed for ambulatory sleep research and home-based multi-night studies. Targeted at clinical researchers in pneumology and neurology.
• Multi-Sensor Headband A sleek, non-invasive headband device worn by patients to comfortably record multi-channel EEG, EOG, and PPG data during sleep studies conducted in home settings. Designed for clinical researchers conducting ambulatory sleep research.
• Simple Patient App An intuitive mobile application that guides patients throughout the sleep recording process, facilitating easy data collection in home environments. Targets patients participating in clinical sleep research studies.
• Centralized Researcher Portal A comprehensive web-based dashboard enabling researchers to monitor study progress, assess participant adherence, oversee data collection, manage participants, and access real-time analytics and data export. Targets clinical researchers running sleep studies.
• EEG Analysis Platform The integrated data portal that processes and analyzes collected sleep data, validated against polysomnography gold-standard for clinical research. Notified as Swissmedic Medical Device Class I (CH-202106-0020). Targets clinical researchers in pneumology and neurology.

Quantifiable outcome

• High statistical agreement with polysomnography gold-standard
• +2 more outcomes

Named customers3 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature5 records

Partnerships

Eleven partnerships are on record, tiered core and minor.

• Blue Lion Acceleration ProgramcoreStrategic or Co-development Partner · 23 April 2025Zurich's leading startup hub and incubator. The acceleration program supports early-stage companies through a rigorous curriculum providing access to curated network of experts, mentors, and investors. Focuses heavily on software solutions in the digital health sector with patient-centric innovation goals for Swiss healthcare system.
• Universitätsspital BaselcoreStrategic or Co-development PartnerMajor research hospital partner using Rekonas platform for sleep studies. Dr. Med. Matthias Herrmann from the Department of Pneumology co-authored research on PRISm and sleep apnea published in ERJ Open Research journal.
• Universitäts-Kinderspital beider Basel (UKBB)coreStrategic or Co-development PartnerChildren's hospital research partner supporting sleep research initiatives in Basel region.
• Chips-JU (EU Chips Joint Undertaking)minorStrategic or Co-development PartnerEuropean research initiative supporting Rekonas through Chips-JU program for microelectronics and sensing technology development.
• BRIDGE - Proof of ConceptminorStrategic or Co-development PartnerSwiss proof-of-concept funding and support program for innovative technologies in healthcare.
• Swiss Healthtech Center (SIPBB)minorStrategic or Co-development PartnerSwiss Healthtech Center supporting healthcare innovation and research initiatives.
• State Secretariat for Education, Research and Innovation (SERI)minorStrategic or Co-development PartnerSwiss federal office supporting education, research, and innovation programs.
• DayOne AcceleratorminorStrategic or Co-development PartnerHealthcare and biotech accelerator program in Switzerland supporting innovative health technology companies.
• Innosuisse - Swiss Innovation AgencyminorStrategic or Co-development PartnerSwiss innovation agency supporting research and development projects.
• University of BaselcoreStrategic or Co-development PartnerAcademic research institution partner providing scientific collaboration and research support for sleep technology development.
• Basel Area SwissminorStrategic or Co-development PartnerRegional economic development organization supporting innovation and business development in Basel region.

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Emerging players

• Oura: Oura's smart ring provides consumer sleep tracking and recently expanded into research-grade features (e.g., detailed sleep staging). An emerging player moving into the sleep-research and longitudinal-cohort use cases that Rekonas addresses with a more clinically robust EEG headband.
• X-trodes: X-trodes develops wireless, dry-electrode multi-sensor EEG/EMG/EOG wearable patches for real-world brain and sleep monitoring. Overlaps with Rekonas on multi-channel ambulatory EEG acquisition for research and clinical applications, though with a patch rather than headband form factor.
• Beacon Biosignals: Beacon Biosignals provides AI-powered EEG analysis for sleep and neurological disorders, partnering with pharma and academic groups running large-scale sleep studies. Comparable to Rekonas as a software/analytics layer that competes on accuracy and scale of EEG-based sleep analysis even though hardware-agnostic.

Direct peers

• Dreem: Dreem (formerly Rythm) builds dry-EEG headbands for sleep research and consumer use, with integrated machine-learning sleep staging. Strong product overlap with Rekonas (dry EEG headband, multi-night recordings, researcher/consumer versions) makes Dreem a closely comparable direct peer.
• Nox Medical: Nox Medical (A/S) manufactures the Nox A1s and other ambulatory PSG systems used in home sleep studies worldwide. Like Rekonas, Nox targets clinical researchers and sleep labs seeking at-home multi-night recordings, making it a near-direct rival in the ambulatory sleep research space.
• Compumedics: Compumedics is a global leader in sleep diagnostics with PSG/HST hardware and the Noxturnal analysis software suite. Rekonas competes head-on in ambulatory sleep research, replacing lab-based PSG with a home EEG headband plus researcher portal — same end-customer (sleep researchers/clinicians), different delivery model.

Others

• Brain Products: Brain Products (LiveAmp, actiCHamp) is an established supplier of research-grade EEG hardware and software (BrainVision Analyzer) used widely in academic sleep and neurology labs. Comparable as part of the broader EEG/sleep-research tooling stack that sleep labs may choose between alongside or in combination with Rekonas.

Broad incumbents

• ResMed: ResMed is the global leader in sleep apnea therapy (CPAP/APAP) and adjacent diagnostic tools (e.g., home sleep testing, cloud platforms like myAir and AirView). Overlaps with Rekonas in the broader sleep-health stack and increasingly in connected diagnostics and software platforms for sleep clinicians.
• Natus Medical: Natus Medical (now part of Natus/Integra) supplies a broad portfolio of neurodiagnostic and sleep-lab equipment (PSG, EEG systems) to hospitals and research institutions. A large incumbent whose PSG/HST products sit alongside Rekonas in the same buying decisions, though Natus addresses a wider portfolio of neurodiagnostic use cases.
• Philips Sleep & Respiratory Care: Philips' Sleep & Respiratory Care business offers Alice NightOne and other home sleep testing devices along with diagnostic software. A broad incumbent in PSG/HST that competes with Rekonas for institutional sleep research and diagnostic customers, especially in Europe.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/rekonas

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rekonas